MERSANA THERAPEUTICS INC's ticker is MRSN and the CUSIP is 59045L106. A total of 134 filers reported holding MERSANA THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $16,522 | -66.9% | 8,220 | -26.2% | 0.00% | – |
| Q1 2024 | $49,930 | +17.9% | 11,145 | -38.9% | 0.00% | – |
| Q4 2023 | $42,338 | -66.3% | 18,249 | -81.6% | 0.00% | – |
| Q3 2023 | $125,678 | -63.7% | 98,959 | -6.1% | 0.00% | – |
| Q2 2023 | $346,588 | -19.3% | 105,346 | +0.8% | 0.00% | -100.0% |
| Q1 2023 | $429,622 | -29.8% | 104,531 | +0.1% | 0.00% | 0.0% |
| Q4 2022 | $612,212 | -11.5% | 104,473 | +2.1% | 0.00% | 0.0% |
| Q3 2022 | $692,000 | +47.2% | 102,344 | +0.6% | 0.00% | 0.0% |
| Q2 2022 | $470,000 | +46.4% | 101,735 | +26.6% | 0.00% | – |
| Q1 2022 | $321,000 | -40.9% | 80,349 | -7.9% | 0.00% | -100.0% |
| Q4 2021 | $543,000 | -31.2% | 87,246 | +4.2% | 0.00% | 0.0% |
| Q3 2021 | $789,000 | -38.8% | 83,710 | -11.8% | 0.00% | -50.0% |
| Q2 2021 | $1,289,000 | -0.8% | 94,917 | +18.2% | 0.00% | 0.0% |
| Q1 2021 | $1,299,000 | -39.4% | 80,270 | -0.4% | 0.00% | -33.3% |
| Q4 2020 | $2,144,000 | -30.7% | 80,560 | -51.5% | 0.00% | -40.0% |
| Q3 2020 | $3,092,000 | +91.1% | 166,060 | +140.1% | 0.01% | +66.7% |
| Q2 2020 | $1,618,000 | +396.3% | 69,156 | +23.6% | 0.00% | +200.0% |
| Q1 2020 | $326,000 | +2.8% | 55,932 | +1.2% | 0.00% | 0.0% |
| Q4 2019 | $317,000 | +264.4% | 55,293 | 0.0% | 0.00% | – |
| Q3 2019 | $87,000 | -61.2% | 55,293 | 0.0% | 0.00% | – |
| Q2 2019 | $224,000 | +124.0% | 55,293 | +190.1% | 0.00% | – |
| Q1 2019 | $100,000 | +28.2% | 19,058 | 0.0% | 0.00% | – |
| Q4 2018 | $78,000 | -59.2% | 19,058 | 0.0% | 0.00% | – |
| Q3 2018 | $191,000 | -43.8% | 19,058 | 0.0% | 0.00% | -100.0% |
| Q2 2018 | $340,000 | +26.4% | 19,058 | +11.9% | 0.00% | 0.0% |
| Q1 2018 | $269,000 | +99.3% | 17,035 | +107.7% | 0.00% | – |
| Q4 2017 | $135,000 | -4.9% | 8,200 | 0.0% | 0.00% | – |
| Q3 2017 | $142,000 | – | 8,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 8,663,673 | $28,503,484 | 2.94% |
| Logos Global Management LP | 2,800,000 | $9,212,000 | 1.25% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 1,100,000 | $3,619,000 | 1.12% |
| 5AM Venture Management, LLC | 1,305,000 | $4,293,450 | 1.07% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 1,000,000 | $3,290,000 | 1.02% |
| Decheng Capital Management III (Cayman), LLC | 904,268 | $2,975,042 | 0.93% |
| Sarissa Capital Management LP | 2,632,900 | $8,662,241 | 0.86% |
| DAFNA Capital Management LLC | 810,845 | $2,667,680 | 0.73% |
| Tri Locum Partners LP | 428,307 | $1,409,130 | 0.52% |
| Avidity Partners Management LP | 3,790,000 | $12,469,100 | 0.44% |